Phoenix PharmaLabs
Addressing the opioid crisis by developing potent, safe, non-addictive painkillers.
Overview
Raised: $0
Rolling Commitments ($USD)
01/30/2021
$0
2002
Healthcare & Pharmaceuticals
HealthTech
B2B2C
High
High
Raise History
Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
Phoenix PharmaLabs | 06/17/2021 | Netcapital | $26,790,283 | $1,065,500 | Equity - Common | Funded | RegCF |
Phoenix PharmaLabs | 01/29/2021 | Netcapital | $26,790,283 | $0 | Equity - Common | Funded | Test the Waters |
Phoenix PharmaLabs | 03/29/2019 | Netcapital | $23,136,335 | $1,102,553 | Equity - Common | Funded | RegCF / RegD 506(c) |
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual